Humanized monoclonal antibodies that target VE-PTP (HPTP-β)

摘要

The disclosure provides compositions and methods for the treatment of ocular conditions associated with angiogenesis comprising administering an antibody that targets a tyrosine phosphatase inhibitor in a subject.